Orexo Logo

Orexo

ORX | ST

Overview

Corporate Details

ISIN(s):
SE0000736415 (+2 more)
LEI:
549300LJ5CCWDPTK9Z08
Country:
Sweden
Address:
Box 303, 751 05 UPPSALA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Orexo is a commercial-stage specialty pharmaceutical company that develops and commercializes improved pharmaceuticals based on proprietary and innovative drug delivery technologies. The company primarily focuses on addressing unmet medical needs in therapeutic areas such as opioid use disorder (OUD) and pain management. Its key commercialized product is Zubsolv®, a treatment for OUD. With over 30 years of experience, Orexo manages the entire product lifecycle from research and development to commercialization, maintaining a significant presence in the US market.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Orexo. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-16 08:00
Interim Report
Swedish 6.7 MB
2025-07-16 08:00
Interim Report
English 6.6 MB
2025-06-30 17:30
Declaration of Voting Results & Voting Rights Announcements
Antal aktier och röster i Orexo
Swedish 76.3 KB
2025-06-30 17:30
Declaration of Voting Results & Voting Rights Announcements
Number of shares and votes in Orexo
English 76.6 KB
2025-06-25 11:38
Major Shareholding Notification
Swedish 9.8 KB
2025-06-19 16:40
Major Shareholding Notification
Swedish 9.9 KB
2025-06-18 18:00
Share Issue/Capital Change
Emission och återköp av C-aktier
Swedish 166.4 KB
2025-06-18 18:00
Share Issue/Capital Change
Issue and repurchase of class C shares
English 168.1 KB
2025-05-08 17:15
Post-Annual General Meeting Information
Report from Orexo AB’s annual general meeting 8 May 2025
English 175.7 KB
2025-05-08 17:15
Post-Annual General Meeting Information
Kommuniké från Orexo AB:s årsstämma den 8 maj 2025
Swedish 148.7 KB
2025-05-06 08:00
Quarterly Report
Swedish 4.6 MB
2025-05-06 08:00
Interim Report
English 4.6 MB
2025-02-06 08:00
Regulatory News Service
Swedish 5.3 MB
2025-02-06 08:00
Annual / Quarterly Financial Statement
English 5.3 MB
2024-12-18 11:45
Post-Annual General Meeting Information
Kommuniké från Orexo AB:s extra bolagsstämma den 18 december 2024
Swedish 124.4 KB

Automate Your Workflow. Get a real-time feed of all Orexo filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Orexo via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-11 Nikolaj Arrild Sørensen Other Buy 2,460 35,178.00 SEK
2025-04-04 Nikolaj Arrild Sørensen Other Buy 3,500 47,530.00 SEK
2024-03-26 Fredrik Järrsten Other Buy 3,000 44,040.00 SEK
2023-11-24 Charlotte Vithlani Hansson Other Buy 3,000 44,640.00 SEK
2023-11-08 Fredrik Järrsten Other Buy 1,500 23,715.00 SEK
2023-02-24 Nikolaj Arrild Sørensen Other Buy 11,500 188,945.00 SEK
2023-01-27 Fredrik Järrsten Other Buy 4,500 79,695.00 SEK
2022-07-26 Michael Matly Other Buy 2,820 60,777.77 SEK
2022-07-21 Charlotte Vithlani Hansson Other Buy 3,000 61,500.00 SEK
2022-07-15 James Noble Other Buy 18,500 394,252.80 SEK

Peer Companies

Company Country Ticker View
CELADON PHARMACEUTICALS PLC Logo
Vertically integrated pharma developing cannabis medicines for chronic pain.
United Kingdom CEL
Celon Pharma S.A. Logo
An integrated biopharma company developing drugs for neurology and cancer, from R&D to market.
Poland CLN
Chemical Works of Gedeon Richter Plc Logo
Develops and markets drugs for women's health, CNS, and cardiovascular conditions worldwide.
Hungary RICHT
Chiome Bioscience Inc. Logo Japan 4583
Chordia Therapeutics,Inc Logo Japan 190A
CHUGAI PHARMACEUTICAL CO., LTD. Logo Japan 4519
CHUKYOIYAKUHIN CO.,LTD. Logo Japan 4558
co.don AG Logo
Develops personalized cartilage cell transplants for minimally invasive joint repair.
Germany CNW
Corline Biomedical AB Logo
Develops heparin-based coatings for medical device biocompatibility and regenerative medicine.
Sweden CLBIO
Cosma Spolka Akcyjna Logo
Produces natural hemp supplements and pharmaceutical raw materials for retail & wholesale markets.
Poland COS